Screening for nuchal translucency

In the case of chromosomally abnormal fetuses where there is a risk of physical and mental handicap, the couple may wish to continue the pregnancy or undergo termination. [...]examining for increased nuchal translucency, which is associated with an increased risk for aneuploidy, 2 is an essential co...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMJ 1998-09, Vol.317 (7160), p.748-750
1. Verfasser: Carroll, Stephen
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 750
container_issue 7160
container_start_page 748
container_title BMJ
container_volume 317
creator Carroll, Stephen
description In the case of chromosomally abnormal fetuses where there is a risk of physical and mental handicap, the couple may wish to continue the pregnancy or undergo termination. [...]examining for increased nuchal translucency, which is associated with an increased risk for aneuploidy, 2 is an essential component of first trimester ultrasound assessment. Occasionally the nuchal abnormality is so obvious that it can be seen without making a formal measurement. Since increased translucency may also be associated with other chromosomal abnormalities (including trisomy 13 and trisomy 18), cardiac abnormalities, and a number of genetic syndromes, this may create a dilemma for the ultrasound operator if a patient has declined nuchal assessment.
doi_str_mv 10.1136/bmj.317.7160.748
format Article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_journals_1777600738</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>25180377</jstor_id><sourcerecordid>25180377</sourcerecordid><originalsourceid>FETCH-LOGICAL-b3248-44ea05f271f09f53fb875e0313d516b326e836591d7e0a718973a3a725d8a1ad3</originalsourceid><addsrcrecordid>eNqFkE1Lw0AQhhdRaqm9exEqHiVxJ5Pd2RylqBWqIn5cl22y0cY2qbsJ2H_vlkivnubwPjPv8DB2CjwGQHm1WFcxAsUEkseUqgM2hFSqSCjEQzbkmcgiBaiO2dj7inOeIKlMigEbZIQJCj5k5y-5s7Ze1h-TsnGTuss_zWrSOlP7VZfbOt-esKPSrLwd_80Re7u9eZ3OovnT3f30eh4tMElVlKbWcFEmBCXPSoHlQpGwHAELATIw0iqUIoOCLDcEKrxg0FAiCmXAFDhiF_3djWu-O-tbXTWdq0OlBiKSnBOqQPGeyl3jvbOl3rjl2ritBq53VnSwooMVvbOig5WwctavVL5t3J5PBCiORCGP-nzpW_uzz4370pKQhH58n2r1LBKcPaQaAn_Z87umf9t_AUbJdog</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1777600738</pqid></control><display><type>article</type><title>Screening for nuchal translucency</title><source>Jstor Complete Legacy</source><source>Alma/SFX Local Collection</source><creator>Carroll, Stephen</creator><creatorcontrib>Carroll, Stephen</creatorcontrib><description>In the case of chromosomally abnormal fetuses where there is a risk of physical and mental handicap, the couple may wish to continue the pregnancy or undergo termination. [...]examining for increased nuchal translucency, which is associated with an increased risk for aneuploidy, 2 is an essential component of first trimester ultrasound assessment. Occasionally the nuchal abnormality is so obvious that it can be seen without making a formal measurement. Since increased translucency may also be associated with other chromosomal abnormalities (including trisomy 13 and trisomy 18), cardiac abnormalities, and a number of genetic syndromes, this may create a dilemma for the ultrasound operator if a patient has declined nuchal assessment.</description><identifier>ISSN: 0959-8138</identifier><identifier>EISSN: 1468-5833</identifier><identifier>EISSN: 1756-1833</identifier><identifier>DOI: 10.1136/bmj.317.7160.748</identifier><identifier>PMID: 9732350</identifier><language>eng</language><publisher>London: British Medical Journal Publishing Group</publisher><subject>Abortion ; Birth rate ; Consent ; Counseling ; Defects ; Down syndrome ; Fetus ; Fetuses ; First trimester of pregnancy ; Genetic engineering ; Genetic screening ; Health care industry ; Infants ; Learning disabilities ; Letters ; Medical personnel ; Nuchal translucency measurement ; Pregnancy ; Screening tests ; Ultrasonic imaging ; Ultrasonography ; Womens health</subject><ispartof>BMJ, 1998-09, Vol.317 (7160), p.748-750</ispartof><rights>1998 BMJ Publishing Group Ltd.</rights><rights>Copyright 1998 BMJ</rights><rights>Copyright: 1998 (c) 1998 BMJ Publishing Group Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b3248-44ea05f271f09f53fb875e0313d516b326e836591d7e0a718973a3a725d8a1ad3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/25180377$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/25180377$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,803,27924,27925,58017,58250</link.rule.ids></links><search><creatorcontrib>Carroll, Stephen</creatorcontrib><title>Screening for nuchal translucency</title><title>BMJ</title><addtitle>BMJ</addtitle><description>In the case of chromosomally abnormal fetuses where there is a risk of physical and mental handicap, the couple may wish to continue the pregnancy or undergo termination. [...]examining for increased nuchal translucency, which is associated with an increased risk for aneuploidy, 2 is an essential component of first trimester ultrasound assessment. Occasionally the nuchal abnormality is so obvious that it can be seen without making a formal measurement. Since increased translucency may also be associated with other chromosomal abnormalities (including trisomy 13 and trisomy 18), cardiac abnormalities, and a number of genetic syndromes, this may create a dilemma for the ultrasound operator if a patient has declined nuchal assessment.</description><subject>Abortion</subject><subject>Birth rate</subject><subject>Consent</subject><subject>Counseling</subject><subject>Defects</subject><subject>Down syndrome</subject><subject>Fetus</subject><subject>Fetuses</subject><subject>First trimester of pregnancy</subject><subject>Genetic engineering</subject><subject>Genetic screening</subject><subject>Health care industry</subject><subject>Infants</subject><subject>Learning disabilities</subject><subject>Letters</subject><subject>Medical personnel</subject><subject>Nuchal translucency measurement</subject><subject>Pregnancy</subject><subject>Screening tests</subject><subject>Ultrasonic imaging</subject><subject>Ultrasonography</subject><subject>Womens health</subject><issn>0959-8138</issn><issn>1468-5833</issn><issn>1756-1833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkE1Lw0AQhhdRaqm9exEqHiVxJ5Pd2RylqBWqIn5cl22y0cY2qbsJ2H_vlkivnubwPjPv8DB2CjwGQHm1WFcxAsUEkseUqgM2hFSqSCjEQzbkmcgiBaiO2dj7inOeIKlMigEbZIQJCj5k5y-5s7Ze1h-TsnGTuss_zWrSOlP7VZfbOt-esKPSrLwd_80Re7u9eZ3OovnT3f30eh4tMElVlKbWcFEmBCXPSoHlQpGwHAELATIw0iqUIoOCLDcEKrxg0FAiCmXAFDhiF_3djWu-O-tbXTWdq0OlBiKSnBOqQPGeyl3jvbOl3rjl2ritBq53VnSwooMVvbOig5WwctavVL5t3J5PBCiORCGP-nzpW_uzz4370pKQhH58n2r1LBKcPaQaAn_Z87umf9t_AUbJdog</recordid><startdate>19980912</startdate><enddate>19980912</enddate><creator>Carroll, Stephen</creator><general>British Medical Journal Publishing Group</general><general>British Medical Association</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9.</scope><scope>LK8</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>19980912</creationdate><title>Screening for nuchal translucency</title><author>Carroll, Stephen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b3248-44ea05f271f09f53fb875e0313d516b326e836591d7e0a718973a3a725d8a1ad3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Abortion</topic><topic>Birth rate</topic><topic>Consent</topic><topic>Counseling</topic><topic>Defects</topic><topic>Down syndrome</topic><topic>Fetus</topic><topic>Fetuses</topic><topic>First trimester of pregnancy</topic><topic>Genetic engineering</topic><topic>Genetic screening</topic><topic>Health care industry</topic><topic>Infants</topic><topic>Learning disabilities</topic><topic>Letters</topic><topic>Medical personnel</topic><topic>Nuchal translucency measurement</topic><topic>Pregnancy</topic><topic>Screening tests</topic><topic>Ultrasonic imaging</topic><topic>Ultrasonography</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Carroll, Stephen</creatorcontrib><collection>Istex</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>BMJ</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Carroll, Stephen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Screening for nuchal translucency</atitle><jtitle>BMJ</jtitle><addtitle>BMJ</addtitle><date>1998-09-12</date><risdate>1998</risdate><volume>317</volume><issue>7160</issue><spage>748</spage><epage>750</epage><pages>748-750</pages><issn>0959-8138</issn><eissn>1468-5833</eissn><eissn>1756-1833</eissn><abstract>In the case of chromosomally abnormal fetuses where there is a risk of physical and mental handicap, the couple may wish to continue the pregnancy or undergo termination. [...]examining for increased nuchal translucency, which is associated with an increased risk for aneuploidy, 2 is an essential component of first trimester ultrasound assessment. Occasionally the nuchal abnormality is so obvious that it can be seen without making a formal measurement. Since increased translucency may also be associated with other chromosomal abnormalities (including trisomy 13 and trisomy 18), cardiac abnormalities, and a number of genetic syndromes, this may create a dilemma for the ultrasound operator if a patient has declined nuchal assessment.</abstract><cop>London</cop><pub>British Medical Journal Publishing Group</pub><pmid>9732350</pmid><doi>10.1136/bmj.317.7160.748</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0959-8138
ispartof BMJ, 1998-09, Vol.317 (7160), p.748-750
issn 0959-8138
1468-5833
1756-1833
language eng
recordid cdi_proquest_journals_1777600738
source Jstor Complete Legacy; Alma/SFX Local Collection
subjects Abortion
Birth rate
Consent
Counseling
Defects
Down syndrome
Fetus
Fetuses
First trimester of pregnancy
Genetic engineering
Genetic screening
Health care industry
Infants
Learning disabilities
Letters
Medical personnel
Nuchal translucency measurement
Pregnancy
Screening tests
Ultrasonic imaging
Ultrasonography
Womens health
title Screening for nuchal translucency
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T13%3A30%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Screening%20for%20nuchal%20translucency&rft.jtitle=BMJ&rft.au=Carroll,%20Stephen&rft.date=1998-09-12&rft.volume=317&rft.issue=7160&rft.spage=748&rft.epage=750&rft.pages=748-750&rft.issn=0959-8138&rft.eissn=1468-5833&rft_id=info:doi/10.1136/bmj.317.7160.748&rft_dat=%3Cjstor_proqu%3E25180377%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1777600738&rft_id=info:pmid/9732350&rft_jstor_id=25180377&rfr_iscdi=true